Calpain inhibition decreases myocardial apoptosis in a swine model of chronic myocardial ischemia

Surgery (United States)

Volumn 158, Issue 2, 2015, Pages 445-452

  Potz, Brittany A ^a   Sabe, Ashraf A ^a   Elmadhun, Nassrene Y ^a   Feng, Jun ^a   Liu, Yuhong ^a   Mitchell, Hunter ^a   Quesenberry, Peter ^a   Abid, M Ruhul ^a   Sellke, Frank W ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CASPASE 3; CASPASE 9; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; [1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; BIOLOGICAL MARKER; CALPASTATIN; CARDIOTONIC AGENT; GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PORCINE MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CHRONIC DISEASE; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; EVALUATION STUDY; HEART; HEART MUSCLE; HYPERCHOLESTEROLEMIA; METABOLISM; MYOCARDIAL ISCHEMIA; PIG;

ANIMALS; APOPTOSIS; BIOMARKERS; BLOTTING, WESTERN; CALPAIN; CARDIOTONIC AGENTS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPROTEINS; HEART; HYPERCHOLESTEROLEMIA; IN SITU NICK-END LABELING; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OXIDATIVE STRESS; SWINE;

EID: 84937515580     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.03.034     Document Type: Article

References (21)

1. A. Galassi, K. Reynolds, and J. He Metabolic syndrome and risk of cardiovascular disease: a meta-analysis Am J Med 119 2006 812 819
2. R.J. Lahan, M. Rezaee, M. Post, F.W. Sellke, R.A. Braeckman, D. Hung, and et al. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution Drug Metab Dispos 27 1999 821 826
3. W.A. Baumgartner, S. Burrows, P.J. del Nido, T.J. Gardner, S. Goldberg, R.C. Gorman, and et al. Recommendations of the National Heart, Lung and Blood Institute Working Group on Future Direction in Cardiac Surgery Circulation 111 2005 3007 3013
4. H. El-Tamimi, M. Mansour, T.J. Wargovich, J.A. Hill, R.A. Kerensky, C.R. Conti, and et al. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited Circulation 89 1994 45 51
5. S.W. Werns, J.A. Walton, H.H. Hsia, E.G. Nabel, M.L. Sanz, and B. Pitt Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease Circulation 79 1989 287 291
6. A. Abaci, A. Oguzhan, S. Kahraman, N.K. Eryol, S. Unal, H. Arinc, and et al. Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels Circulation 99 1999 2239 2242
7. M. Boodhwani, and F.W. Sellke Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress Antioxid Redox Signal 11 2009 1945 1959
8. A. Calver, J. Collier, and P. Vallance Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes J Clin Invest 90 1992 2548 2554
9. A.M. Zeiher, H. Drexler, H. Wollschlager, and H. Just Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis Circulation 83 1991 391 401
10. Y. Kudo-Sakamoto, H. Akazawa, K. Ito, J. Takano, M. Yano, C. Yabumoto, and et al. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling J Biol Chem 289 2014 19408 19419
11. S.-I. Yamagishi, D. Edelstein, X.-L. Du, and M. Brownlee Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction Diabetes 50 2001 1491 1494
12. A.S. Galvez, A. Diwan, A.M. Odley, H.S. Hahn, H. Osinska, J.G. Meledez, and et al. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis Circ Res 100 2007 1071 1078
13. P.N. Khalil, C. Neuhof, R. Hiss, M. Pollhammer, M.N. Khalil, H. Neuhob, and et al. Calpain Inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model Eur J Pharmacol 528 2005 124 131
14. T.J. Stalker, Y. Gong, and R. Scalia The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes Diabetes 54 2005 1132 1140
15. M.V. Hoang, J.A. Nagy, J.E.B. Fox, and D.R. Senger Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis PLoS One 5 2010 e13612
16. M.V. Hoang, L.E.H. Smith, and D.R. Senger Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion Biochem Biophys Acta 1812 2011 549 557
17. A.A. Sabe, N.Y. Elmadhun, J. Feng, Y.H. Liu, B.A. Potz, R. Abid, and et al. Calpain inhibition improves myocardial perfusion in a swine model of chronic myocardial ischemia Circulation 130 Suppl 2 2014 A19666
18. M.P. Robich, R.M. Osipov, R. Nezafat, J. Feng, R.T. Clements, C. Bianchi, and et al. Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia Circulation 122 2010 S142 S149
19. N.Y. Elmadhun, A.A. Sabe, M.P. Robich, L.M. Chu, A.D. Lassaletta, and F.W. Sellke The pig as a valuable model for testing the effect resveratrol to prevent cardiovascular disease Ann N Y Acad Sci 1290 2013 130 135
20. S. Kumar, V. Kain, and S.L. Sitasawad High glucose induces Ca 2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and independent pathways Biochem Biophys Acta 1820 2012 907 920
21. J.Y. Youn, T. Want, and H. Cai An exrin/calpain/PI3K/AMPK/eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production Circ Res 104 2009 50 59